Description
COCCIDIOSIS ANTIBODY REAGENT TEST KITS
First action · last action
2024-06-20 · 2025-09-30
Transactions
2
First transaction's obligation
$84,228
Base + all options value (sum of deltas)
$83,553
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C26222A0042
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-06-20+$84,228= $84,228
- Mod P000012025-09-30-$675= $83,553
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-06-20 | +$84,228 | $84,228 | COCCIDIOSIS ANTIBODY REAGENT TEST KITS |
| Mod P00001· FUNDING ONLY ACTION | 2025-09-30 | −$675 | $83,553 | COCCIDIOSIS ANTIBODY REAGENT TEST KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CN4DMLCJGCK9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0595 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $89,358 | FY2026 |
| 36C24926N0334 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $118,846 | FY2026 |
| 36C24926A0032 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26225N0826 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $86,755 | FY2025 |
| 36C24925P0444 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $125,117 | FY2025 |
| 36C24925P0274 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $134,176 | FY2025 |
Other recipients under 6550 from 262-NETWORK CONTRACT OFFICE 22 (36C262) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26226N0941 | POLYMEDCO LLC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $25,596 | FY2026 |
| 36C26226P1513 | GOVERNMENT SCIENTIFIC SOURCE INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $28,264 | FY2026 |
| 36C26226N0903 | BIOMERIEUX INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $67,946 | FY2026 |
| 36C26226N0869 | BECKMAN COULTER, INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $111,853 | FY2026 |
| 36C26226N0897 | BIOMERIEUX INC | 262-NETWORK CONTRACT OFFICE 22 (36C262) | $98,331 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26224N0800_3600_36C26222A0042_3600 · retrieved 2026-09-26.